Inspire Medical Systems (INSP) Competitors $93.20 -2.79 (-2.90%) Closing price 08/25/2025 03:59 PM EasternExtended Trading$93.00 -0.20 (-0.22%) As of 08/25/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSP vs. PEN, STVN, GKOS, BLCO, IRTC, TMDX, SLNO, NVST, LIVN, and WRBYShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Its Competitors Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Penumbra (NYSE:PEN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings. Do analysts prefer PEN or INSP? Penumbra presently has a consensus price target of $300.47, suggesting a potential upside of 13.30%. Inspire Medical Systems has a consensus price target of $165.62, suggesting a potential upside of 77.69%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 2.94Inspire Medical Systems 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54 Which has stronger earnings & valuation, PEN or INSP? Inspire Medical Systems has lower revenue, but higher earnings than Penumbra. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B8.66$14.01M$3.7670.53Inspire Medical Systems$802.80M3.43$53.51M$1.7353.88 Does the media prefer PEN or INSP? In the previous week, Inspire Medical Systems had 9 more articles in the media than Penumbra. MarketBeat recorded 20 mentions for Inspire Medical Systems and 11 mentions for Penumbra. Inspire Medical Systems' average media sentiment score of 1.33 beat Penumbra's score of 0.92 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 14 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of PEN or INSP? 88.9% of Penumbra shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 5.0% of Penumbra shares are held by insiders. Comparatively, 2.3% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is PEN or INSP more profitable? Penumbra has a net margin of 11.54% compared to Inspire Medical Systems' net margin of 6.17%. Penumbra's return on equity of 11.55% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Penumbra11.54% 11.55% 8.76% Inspire Medical Systems 6.17%10.38%8.93% Which has more risk & volatility, PEN or INSP? Penumbra has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. SummaryPenumbra beats Inspire Medical Systems on 10 of the 17 factors compared between the two stocks. Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$2.84B$2.15B$5.82B$21.30BDividend YieldN/AN/A4.40%3.54%P/E Ratio53.8837.4330.1428.85Price / Sales3.4310.00435.1351.02Price / Cash56.1853.5525.7818.23Price / Book4.0510.749.424.69Net Income$53.51M-$63.67M$3.27B$995.89M7 Day Performance3.56%3.56%3.64%2.23%1 Month Performance-27.77%0.59%3.52%2.46%1 Year Performance-50.67%26.13%29.95%10.46% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.9374 of 5 stars$93.20-2.9%$165.62+77.7%-51.3%$2.84B$802.80M53.881,246Positive NewsPENPenumbra4.7437 of 5 stars$255.35+0.9%$300.47+17.7%+26.2%$9.96B$1.28B67.914,500Positive NewsSTVNStevanato GroupN/A€22.50-0.5%N/A+18.2%€6.81B€1.19B41.675,521GKOSGlaukos4.7106 of 5 stars$89.47-0.4%$127.42+42.4%-30.9%$5.13B$432.95M-54.22780Analyst RevisionBLCOBausch + Lomb1.6062 of 5 stars$14.49-0.4%$15.56+7.4%-10.5%$5.13B$4.79B-18.5713,500IRTCiRhythm Technologies1.3017 of 5 stars$157.93-1.7%$157.30-0.4%+136.7%$5.07B$591.84M-53.902,000Insider TradeTMDXTransMedics Group2.7556 of 5 stars$125.65-1.5%$123.00-2.1%-34.5%$4.28B$441.54M65.10210Positive NewsAnalyst ForecastSLNOSoleno Therapeutics4.6161 of 5 stars$68.09-4.9%$114.30+67.9%+47.0%$3.62BN/A-16.4530News CoverageNVSTEnvista3.6875 of 5 stars$20.75+0.5%$20.92+0.9%+13.1%$3.45B$2.51B64.8312,300LIVNLivaNova1.6246 of 5 stars$53.27-0.8%$59.29+11.3%+20.9%$2.91B$1.25B-13.692,900News CoveragePositive NewsWRBYWarby Parker2.174 of 5 stars$27.38+0.9%$24.06-12.1%+68.8%$2.88B$771.32M-391.093,780Analyst Upgrade Related Companies and Tools Related Companies Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives iRhythm Technologies Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INSP) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.